CDC suddenly discovered that it is becoming harder to get people to get vaccinated unless you show some rewards that go with it. So poof!. The science changed.
It takes years to develop good science. We live in a world where we think science is like ordering a cheeseburger and lose our collective shit when it’s not perfect right away. The truth is that science is a process of trial and err, and it takes a lot of time and effort to get the right answer.
Okay, so what changed the science from just two weeks ago when the "experts" were saying that we needed to be wearing masks outside - preferable two- because we were at risk of another wave and reversing all our progress? Oh, I see. The experts in the focus groups and the fact that rebellions in the states were looking bad and DeSantis types were lookin good. Yeh, gotta follow "the experts."
Oh I dunno. Governor Cuomo got an emmy and nation-wide accolades for following the science and keeping the politics and personal goals out of his covid management. So there is someone right there who the dems say has been successful.
First of all, I don’t think dropping something like this with no heads up or transition time was smart. I think they should have set a vaccination rate threshold for states. However, the CDC cited the case levels and downward trajectory of cases. I also know moderna just released a larger study showing a higher rate of protection than the 94% originally cited and recently another study showed more than 99% of the Covid patients hospitalized were unvaccinated. I actually don’t think this incentivizes people to get vaccinated but I also know these mask laws come down to the states and private businesses can require you to wear a bee keeper suit if they want so let the fun begin.
What if for example, a person's religion causes them to refuse to wear a mask, such as muslims. Are they still good to go? heh, just ticklin your butt.
Delayed second Pfizer COVID-19 shot produces more antibodies -study https://www.reuters.com/business/he...ot-produces-more-antibodies-study-2021-05-13/ Pfizer's (PFE.N) COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study said. The study released on Friday is the first to directly compare immune responses of the Pfizer shot from the three-week dosing interval tested in clinical trials, and the extended 12-week interval that British officials recommend in order to give more vulnerable people at least some protection quickly. After Britain moved to extend the interval between doses, Pfizer and vaccine partner BioNTech said there was no data to back up the move. However, Pfizer has said that public health considerations outside of the clinical trials might be taken into consideration. read more "Our study demonstrates that peak antibody responses after the second Pfizer vaccine are markedly enhanced in older people when this is delayed to 12 weeks," Helen Parry, an author of the study based at the University of Birmingham, said. Britain began rolling out Pfizer's vaccine before changing dosing policy, meaning a small number of people who got the shot early received the second shot three weeks later. The study, which has not yet been peer-reviewed, looked at 175 people aged between 80 and 99, and found that extending the second dose interval to 12 weeks increased the peak antibody response 3.5-fold compared to those who had it at three weeks. Antibodies are one part of the immune system, and vaccines also generate T cells. The peak T cell responses were higher in the group with a 3 week interval between doses, and the authors warned against drawing conclusions on how protected individuals were based on which dosing schedule they received. However, taken with data showing good protection against hospitalisation and death from just one shot of Pfizer vaccine, Public Health England said the study was further supportive evidence in favour of Britain's approach. "The approach taken in the UK for delaying that second dose has really paid off," Gayatri Amirthalingam, Consultant Epidemiologist at Public Health England, told reporters.